D. E. Shaw & Co., Inc. Trillium Therapeutics Inc. Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
Shares
6 transactions
About Trillium Therapeutics Inc.
- Ticker TRIL
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 104,995,000
- Market Cap $1.94B